B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MAPKAP1

MOLECULAR TARGET

MAPK associated protein 1

UniProt: Q9BPZ7NCBI Gene: 791092 compounds

MAPKAP1 (MAPK associated protein 1) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MAPKAP1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Ku 0063794 [Supplementary Concept]1.102
2torin 11.102

About MAPKAP1 as a Drug Target

MAPKAP1 (MAPK associated protein 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented MAPKAP1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MAPKAP1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.